Home Eli Lilly, Incyte drug fares well in late-stage research
 

Keywords :   


Eli Lilly, Incyte drug fares well in late-stage research

2015-09-29 16:11:28| Biotech - Topix.net

A potential rheumatoid arthritis treatment from Eli Lilly and Incyte fared better than another drug in late-stage testing, and the drugmakers are moving closer to seeking regulatory approval to sell it. Lilly said Tuesday that early results from a study that enrolled around 600 patients showed that its oral medication, baricitinib, proved superior to the established treatment methotrexate.

Tags: research drug eli lilly

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
14.11AKB48 1st
14.11kindle 10
14.11
14.11YAMAHA PORTATONE PSR-340
14.112003 112
14.11 14533.5
14.11caligari 17
14.11 amnjx 27circus
More »